Shehla Shakoor - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Shehla Shakoor's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Shehla Shakoor
Verified
Managing Director, Endpoints News
Lawrence
Beats
travel photojournalism, travel feminism, health and well-being and celebrity interviews news,Social affairs women's interest
backpackers
Content
By Shehla Shakoor| Endpoints News Verified R.W. Baird Health Care Conference The best place to read Endpoints News? In your inbox. Comprehensive daily news report for those who discover, develop, and market drugs. Join 33,900+ biopharma pros who read Endpoints News by email every day. Free Subscription Read next LATEST FEATURED Subscribe to Endpoints News Thank you for staying with us. It's great to have you on board! Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?...
By Shehla Shakoor| Endpoints News Verified Ionis is teaming up with Roche again, this time to develop an antisense drug for dry AMD with an upfront payment of $75 million to the biotech and up to $684 million more possible on the backend. Initially optioned to GSK, IONIS-FB-LRx was dumped alongside inotersen during GSK’s rare disease pipeline upheaval last summer.
By Shehla Shakoor| Endpoints News Verified R.W. Baird Health Care Conference The best place to read Endpoints News? In your inbox. Comprehensive daily news report for those who discover, develop, and market drugs. Join 33,900+ biopharma pros who read Endpoints News by email every day. Free Subscription Read next LATEST FEATURED Subscribe to Endpoints News Thank you for staying with us. It's great to have you on board! Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?...
Company Info
Endpoints News
Endpoints News is an independent news organization dedicated to the biopharmaceutical industry. Founded in 2016 by Arsalan Arif and John Carroll, it has established itself as a trusted source of information, boasting over 163,000 subscribers, including executives and scientific leaders from top pharmaceutical companies and biotech startups worldwide. The organization provides daily news reports, analysis, and events tailored for biopharma professionals. Its offerings include daily newsletters like the Early Edition, investigative reporting on drug development and regulatory updates, and in-person and virtual conferences such as the Endpoints Summit. Endpoints News emphasizes independent journalism and operates on a subscription model, providing premium content to subscribers while maintaining ad-free reporting. With a focus on both scientific and business aspects of the industry, it serves decision-makers across the global pharmaceutical landscape.
Lawrence, Kansas, United States
+1 785-813-1733
Founded: 2014